ClinicalTrials.Veeva

Menu

A Pre-post Intervention Study Evaluating Home-based Management of Patients With COPD or CAP

C

Current Health

Status

Withdrawn

Conditions

Community-acquired Pneumonia
Chronic Obstructive Pulmonary Disease

Treatments

Device: Current Health platform

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05009485
SSH_2021

Details and patient eligibility

About

Risk of rehospitalization within 30 days of discharge is higher than 20% in patients with chronic obstructive pulmonary disease (COPD) and up to 20% for patients with community acquired pneumonia (CAP). This pre-post intervention study aims to quantify the impact of continuous remote patient monitoring (RPM) on rates of hospital readmission for patients presenting with CAP or exacerbation of COPD and compare the intervention group to historical controls that did not have access to the intervention. We hypothesize that an intervention combining remote patient monitoring with the remote clinical services and escalation pathways available at SSH (including the Mobile Integrated Health (MIH) program) will reduce hospital readmission within the 30 days following hospital discharge compared to standard of care in this population.

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 21 years or older
  • confirmed diagnosis of moderate-severe COPD or community acquired pneumonia
  • attendance at South Shore Hospital with an exacerbation of COPD / CAP
  • fit for discharge to home

Exclusion criteria

  • suspicion of COVID-19 or confirmed COVID-19 positive
  • life-threatening exacerbation requiring invasive ventilation or prolonged stay in critical care (> 24 hours)
  • unable/unwilling to use Current Health
  • bilateral axillary lymph node dissection
  • persistent atrial fibrillation
  • heavy tattooing on upper arms
  • discharged to skilled nursing facility
  • no access to home or mobile telephone

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Intervention
Experimental group
Description:
Participants will be remotely monitored with the Current Health platform, respond to daily respiratory surveys, receive daily medication reminders and an action plan. Daily dashboard rounds and vital sign alarms from the continuously collected vital signs will be used to identify changes in health and escalated accordingly.
Treatment:
Device: Current Health platform

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems